Ibn-Alhaytham Hospital Co (P.S.C) (ASE:IBNH)
0.7500
-0.0300 (-3.85%)
At close: Sep 17, 2026
ASE:IBNH Ratios and Metrics
Market cap in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15 | 19 | 14 | 18 | 16 | 21 | |
Market Cap Growth | 8.70% | 35.71% | -23.91% | 15.00% | -24.53% | -9.40% |
Enterprise Value | 26 | 29 | 23 | 27 | 19 | 23 |
Last Close Price | 0.75 | 0.95 | 0.70 | 0.92 | 0.80 | 1.06 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 58.74 | 146.27 | - | - | - |
PS Ratio | 1.28 | 1.57 | 1.19 | 1.62 | 1.43 | 1.71 |
PB Ratio | 1.13 | 1.40 | 1.17 | 1.28 | 0.87 | 0.98 |
P/TBV Ratio | 1.13 | 1.40 | 1.17 | 1.28 | 0.87 | 0.98 |
P/FCF Ratio | - | - | 44.05 | - | - | 50.56 |
P/OCF Ratio | 8.00 | 11.77 | 8.20 | - | - | 19.41 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.20 | 2.37 | 1.95 | 2.35 | 1.74 | 1.84 |
EV/EBITDA Ratio | 18.26 | 16.09 | 13.93 | 43.81 | 34.63 | 15.36 |
EV/EBIT Ratio | 85.57 | 38.64 | 42.79 | - | - | - |
EV/FCF Ratio | - | - | 72.42 | - | - | 54.24 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.81 | 0.77 | 0.76 | 0.61 | 0.24 | 0.10 |
Debt / EBITDA Ratio | 7.76 | 5.84 | 5.53 | 14.49 | 7.88 | 1.45 |
Debt / FCF Ratio | - | - | 28.74 | - | - | 5.11 |
Net Debt / Equity Ratio | 0.81 | 0.76 | 0.74 | 0.59 | 0.23 | 0.08 |
Net Debt / EBITDA Ratio | 7.71 | 5.75 | 5.37 | 14.00 | 7.54 | 1.23 |
Net Debt / FCF Ratio | -16.96 | -17.35 | 27.93 | -2.35 | -1.92 | 4.36 |
Asset Turnover | 0.37 | 0.42 | 0.41 | 0.37 | 0.36 | 0.40 |
Inventory Turnover | 2.99 | 3.33 | 3.96 | 5.39 | 5.57 | 4.00 |
Quick Ratio | 0.37 | 0.42 | 0.45 | 0.61 | 0.76 | 1.07 |
Current Ratio | 0.57 | 0.61 | 0.64 | 0.76 | 0.91 | 1.25 |
Return on Equity (ROE) | -1.04% | 2.53% | 0.73% | -15.36% | -13.28% | -2.63% |
Return on Assets (ROA) | 0.56% | 1.60% | 1.18% | -2.04% | -3.04% | -1.18% |
Return on Invested Capital (ROIC) | 1.16% | 2.86% | 2.46% | -4.37% | -6.59% | -2.45% |
Return on Capital Employed (ROCE) | 2.10% | 5.40% | 4.30% | -6.80% | -8.10% | -2.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.96% | 1.70% | 0.68% | -13.73% | -16.64% | -2.74% |
FCF Yield | -4.21% | -3.12% | 2.27% | -19.68% | -13.77% | 1.98% |